T1	DISO 34 43	hipotonía
#1	AnnotatorNotes T1	C0026827; Muscle hypotonia; Finding
T2	DISO 45 56	decaimiento
#2	AnnotatorNotes T2	C0344315; Depressed mood; Mental or Behavioral Dysfunction
T3	DISO 59 76	perdida de fuerza
#3	AnnotatorNotes T3	C3714552; Weakness; Sign or Symptom
T4	Duration 81 93	varios meses
T5	LIVB 128 133	Mujer
#4	AnnotatorNotes T5	C0043210; Woman; Population Group | C0242665; wife; Family Group
T6	Age 137 144	49 años
T7	PROC 146 164	institucionalizada
T8	DISO 169 180	dependencia
#5	AnnotatorNotes T8	C0439857; Dependence; Mental or Behavioral Dysfunction | C1510472; Drug Dependence; Mental or Behavioral Dysfunction
T9	DEVI 205 220	silla de ruedas
#6	AnnotatorNotes T9	C0043143; wheelchair; Medical Device
T10	Neg_cue 252 254	No
T11	DISO 255 289	reacciones adversas a medicamentos
T12	Negated 255 289	reacciones adversas a medicamentos
T13	DISO 294 341	Esclerosis Múltiple forma secundaria progresiva
T14	PROC 372 385	diagnosticada
#7	AnnotatorNotes T14	C0011900; Diagnosis; Diagnostic Procedure
T15	Age 392 399	17 años
T16	PROC 404 415	seguimiento
#8	AnnotatorNotes T16	C0420316; Other follow-up; Health Care Activity
T17	PROC 444 447	RMN
#9	AnnotatorNotes T17	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T18	Date 451 455	2018
T19	DISO 465 491	afectación desmielinizante
T20	ANAT 512 526	cordón medular
T21	DISO 552 588	lesiones subcortical insular derecha
T22	ANAT 597 627	subcortical temporal izquierda
T23	PROC 635 646	Tratamiento
#10	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	CHEM 651 666	interferón beta
#11	AnnotatorNotes T24	C0015980; interferon-beta; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance | C0751599; Recombinant Interferon Beta; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T25	CHEM 668 680	mitoxantrona
#12	AnnotatorNotes T25	C0026259; mitoxantrone; Organic Chemical · Pharmacologic Substance
T26	CHEM 682 696	ciclofosfamida
#13	AnnotatorNotes T26	C0010583; cyclophosphamide; Organic Chemical · Pharmacologic Substance
T27	CHEM 699 709	fingolimod
#14	AnnotatorNotes T27	C1699926; fingolimod; Immunologic Factor · Organic Chemical · Pharmacologic Substance
T29	CHEM 729 740	ocrelizumab
#15	AnnotatorNotes T29	C1882138; ocrelizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T30	DISO 744 760	Vejiga espástica
#16	AnnotatorNotes T30	C0877419; Automatic bladder; Pathologic Function
T31	DISO 765 769	ITUs
T32	PROC 788 799	seguimiento
#17	AnnotatorNotes T32	C0420316; Other follow-up; Health Care Activity
T33	DISO 816 835	Doble incontinencia
T34	DISO 839 862	Asma bronquial alérgico
T35	DISO 866 893	Trastorno maníaco-depresivo
#18	AnnotatorNotes T35	C0005586; Bipolar Disorder; Mental or Behavioral Dysfunction
T36	PROC 899 922	ingreso en Salud Mental
T37	Date 926 930	2017
T38	Neg_cue 933 936	sin
T39	PROC 937 948	seguimiento
#19	AnnotatorNotes T39	C0420316; Other follow-up; Health Care Activity
T40	Negated 937 948	seguimiento
T42	PROC 959 970	Tratamiento
#20	AnnotatorNotes T42	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T44	CHEM 979 989	salmeterol
#21	AnnotatorNotes T44	C0073992; salmeterol; Organic Chemical · Pharmacologic Substance
T45	CHEM 990 1001	fluticasona
#22	AnnotatorNotes T45	C0082607; fluticasone; Organic Chemical · Pharmacologic Substance
T46	Dose 1002 1007	1 inh
T47	Frequency 1007 1012	/12 h
T48	CHEM 1014 1028	levocetiricina
#23	AnnotatorNotes T48	C1174893; levocetirizine; Organic Chemical · Pharmacologic Substance
T49	Dose 1029 1033	5 mg
T50	CHEM 1035 1046	mirtazapina
#24	AnnotatorNotes T50	C0049506; mirtazapine; Organic Chemical · Pharmacologic Substance
T51	Dose 1047 1052	15 mg
T52	CHEM 1054 1064	silodosina
#25	AnnotatorNotes T52	C1870115; silodosin; Organic Chemical · Pharmacologic Substance
T53	Dose 1065 1069	8 mg
T54	CHEM 1071 1083	lormetazepam
#26	AnnotatorNotes T54	C0065185; lormetazepam; Organic Chemical · Pharmacologic Substance
T55	Dose 1084 1088	2 mg
T56	CHEM 1090 1099	espesante
T57	DISO 1104 1114	Enfermedad
#27	AnnotatorNotes T57	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T59	PROC 1124 1130	EXAMEN
#28	AnnotatorNotes T59	C0031809; Physical Examination; Health Care Activity
T60	PROC 1135 1153	Exploración física
#29	AnnotatorNotes T60	C0031809; Physical Examination; Health Care Activity
T61	PROC 1272 1299	Auscultación cardiopulmonar
T62	DISO 1325 1343	debilidad muscular
#30	AnnotatorNotes T62	C0151786; Muscle Weakness; Sign or Symptom
T63	PROC 1348 1371	Pruebas complementarias
#31	AnnotatorNotes T63	C1515980; Ancillary Study; Research Activity
T64	PROC 1375 1377	TA
T65	PROC 1386 1388	FC
T66	PROC 1398 1411	Saturación O2
T67	PROC 1420 1437	Bioquímica sérica
T68	DISO 1451 1464	hipercalcemia
#32	AnnotatorNotes T68	C0020437; Hypercalcemia; Disease or Syndrome
T69	PROC 1495 1498	PTH
#33	AnnotatorNotes T69	C0202159; Parathyroid hormone measurement; Laboratory Procedure
T70	PROC 1570 1581	RMN craneal
T71	Neg_cue 1582 1585	sin
T72	DISO 1593 1601	lesiones
#34	AnnotatorNotes T72	C0221198; Lesion; Finding | C3263723; Traumatic injury; Injury or Poisoning
T73	Negated 1593 1601	lesiones
T74	PROC 1656 1691	ecografía de riñón y vías urinarias
T75	Neg_cue 1692 1695	sin
T76	DISO 1709 1725	cálculos renales
#35	AnnotatorNotes T76	C0022650; Kidney Calculi; Disease or Syndrome | C0392525; Nephrolithiasis; Disease or Syndrome
T77	Negated 1709 1725	cálculos renales
T78	Neg_cue 1726 1728	ni
T79	DISO 1729 1737	adenomas
#36	AnnotatorNotes T79	C0001430; Adenoma; Neoplastic Process
T80	Negated 1729 1737	adenomas
T81	PROC 1741 1768	Gammagrafía de paratiroides
#37	AnnotatorNotes T81	C0860840; Parathyroid scintigraphy; Diagnostic Procedure
T82	PROC 1771 1776	SPECT
#38	AnnotatorNotes T82	C0040399; Tomography, Emission-Computed, Single-Photon; Diagnostic Procedure
T83	PROC 1777 1780	TAC
#39	AnnotatorNotes T83	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T84	Spec_cue 1792 1804	sugerente de
T85	DISO 1805 1828	adenoma de paratiroides
#40	AnnotatorNotes T85	C0154041; Benign neoplasm of parathyroid gland; Neoplastic Process
T86	Speculated 1805 1858	adenoma de paratiroides a nivel retrotiroideo derecho
T87	ANAT 1837 1858	retrotiroideo derecho
T88	PROC 1862 1873	TRATAMIENTO
#41	AnnotatorNotes T88	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T89	Neg_cue 1890 1901	Se descarta
T90	PROC 1905 1927	tratamiento quirúrgico
#42	AnnotatorNotes T90	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T91	Negated 1905 1927	tratamiento quirúrgico
T92	CHEM 1950 1961	Cinalcalcet
T93	Dose 1964 1975	dosis bajas
T94	PROC 1978 1995	Control analítico
T95	LIVB 2012 2029	médico de familia
#43	AnnotatorNotes T95	C1704221; Physicians, Family; Professional or Occupational Group
T96	Duration 2033 2042	4 semanas
T97	DISO 2091 2119	Hiperparatiroidismo primario
#44	AnnotatorNotes T97	C0221002; Hyperparathyroidism, Primary; Disease or Syndrome
T101	ANAT 492 506	supratentorial
#46	AnnotatorNotes T19	Demyelinating Diseases (C0011303)
#47	AnnotatorNotes T13	Multiple Sclerosis, Secondary Progressive (C0751965)
#48	AnnotatorNotes T11	Adverse reaction to drug (C0041755)
#49	AnnotatorNotes T31	Urinary tract infection (C0042029)
T28	PROC 2067 2078	DIAGNÓSTICO
T41	DISO 2127 2155	brote de Esclerosis Múltiple
#50	AnnotatorNotes T41	Multiple sclerosis relapse (C0856120)
#45	AnnotatorNotes T7	Institutionalized C0562359
T43	Date 971 977	actual
T58	Date 1115 1121	actual
T98	Date 713 724	actualmente
T99	Date 949 955	actual
